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Abstract 37 
Neuronal secretion of peptide signaling molecules (neuropeptides) is an evolutionarily ancient 38 
feature of nervous systems. Here we report the identification of twenty cDNAs encoding 39 
putative neuropeptide precursors in the sea urchin Strongylocentrotus purpuratus (Phylum 40 
Echinodermata), providing new insights on the evolution and diversity of neuropeptides. 41 
Identification of a gonadotropin-releasing hormone-like peptide precursor (SpGnRHP) is 42 
consistent with the widespread phylogenetic distribution of GnRH-type neuropeptides in the 43 
bilateria. A protein (SpTRHLP) comprising multiple copies of peptides that share structural 44 
similarity with thyrotropin-releasing hormone (TRH) is the first TRH-like precursor to be 45 
identified in an invertebrate. SpCTLP is the first calcitonin-like peptide with two N-terminally 46 
located cysteine residues to be found in a non-chordate species. Discovery of two proteins 47 
(SpPPLNP1, SpPPLNP2) comprising homologs of molluscan pedal peptides and arthropod 48 
orcokinins indicates the existence of a bilaterian family of pedal peptide/orcokinin-type 49 
neuropeptides. Other proteins identified contain peptides that do not share apparent sequence 50 
similarity with known neuropeptides. These include Spnp5, which comprises multiple copies 51 
of C-terminally amidated peptides that have an N-terminal Ala-Asn motif (AN peptides), and 52 
Spnp9, Spnp10 and Spnp12, which contain putative neuropeptides with a C-terminal Phe-53 
amide, Ser-amide or Pro-amide, respectively. Several proteins (Spnp 11, 14, 15, 16, 17, 18, 19 54 
and 20) contain putative neuropeptides with multiple cysteine residues (2, 6 or 8), which may 55 
mediate formation of intramolecular or intermolecular disulphide bridges. Looking ahead, the 56 
identification of these neuropeptide precursors in Strongylocentrotus purpuratus has provided 57 
a strong basis for a comprehensive analysis of neuropeptide function in this model 58 
echinoderm species. 59 
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1. Introduction 62 
 63 
Neuronal secretion of peptide signaling molecules (neuropeptides) is a fundamental 64 
and evolutionarily ancient feature of nervous systems. Unlike “classical” neurotransmitters 65 
(e.g. acetylcholine, dopamine), which are synthesized by enzymes, neuropeptides are cleaved 66 
from precursor proteins and therefore mutation-induced changes in the amino acid sequences 67 
of neuropeptides can occur over time [42, 75]. Accordingly, it has been proposed that changes 68 
in the sequences and/or the expression of neuropeptide genes may be important in the 69 
evolution of behavior, with neuropeptide genes acting as “volume knobs” that shape adaptive 70 
changes in animal behavior over evolutionary time [5]. Consistent with this notion, 71 
neuropeptides act as mediators and/or regulators of a wide range of behaviors, including 72 
locomotor activity, feeding, reproduction and learning [35, 61]. 73 
Neuropeptides were first discovered on account of their effects as neurohormones on 74 
physiological phenomena such as blood pressure or the contractile activity of visceral organs 75 
and only later was it found that these molecules also act within the central nervous system to 76 
regulate whole-animal behavior. For example, the neuropeptides vasopressin and oxytocin 77 
were discovered as pituitary neurohormones that cause an increase in blood pressure and 78 
uterine contraction, respectively [19]. Subsequently it was found that vasopressin-releasing 79 
and oxytocin-releasing neurons also project to many regions of the central nervous system 80 
[15] and both vasopressin and oxytocin are now known to be key players in neural 81 
mechanisms of social behavior [54, 91]. 82 
Other technical strategies for neuropeptide discovery that have been important include 83 
the use of antibodies to known neuropeptides to enable identification of structurally related 84 
neuropeptides in the same species or in other species [17, 18] and the use of mass 85 
spectroscopic and/or sequencing techniques to identify putative bioactive neuropeptides in 86 
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extracts of neural tissue [29]. More recently, however, it is has been the use of genome 87 
sequencing and/or sequencing of neural cDNA libraries that has transformed neuropeptide 88 
discovery, with comprehensive genome-wide analyses of putative neuropeptide precursor 89 
genes being accomplished in several animal species. For example, when the first animal 90 
genome sequences were obtained for the model organisms Caenorhabditis elegans [77] and 91 
Drosophila melanogaster [1], detailed surveys of candidate neuropeptide precursor genes 92 
were reported [34, 48, 81]. These initial overviews of neuropeptide diversity in 93 
Caenorhabditis elegans and Drosophila melanogaster provided the foundations for 94 
subsequent more detailed studies that have identified the receptors that mediate the effects of 95 
neuropeptides in these animals and have provided new insights on the 96 
physiological/behavioral roles of neuropeptides [33, 47, 53]. 97 
During the last decade or so genome sequencing technology has been applied to an 98 
increasingly wide range of animal species and genome-wide surveys of neuropeptide diversity 99 
have been reported for species belonging to several animal phyla, including annelids [14, 84], 100 
molluscs [83] and cnidarians [4]. Thus, a picture of the diversity of neuropeptides that occur 101 
throughout the animal kingdom and the relationships between these neuropeptides is 102 
beginning to emerge. The picture is still far from complete but we can see on the horizon the 103 
potential for reconstructing the evolutionary history of neuropeptide signaling systems based 104 
upon detailed comparative analysis of the complements and characteristics of neuropeptides 105 
in extant species. 106 
Animals that are important for investigation of the phylogenetic distribution and 107 
evolution of neuropeptides are the deuterostomian invertebrates because they provide a link 108 
between vertebrates (also deuterostomes) and the protostomian invertebrates, which include 109 
phyla such as arthropods (e.g. Drosophila), nematodes (e.g. C. elegans), molluscs and 110 
annelids. Genome sequences have been obtained for urochordate and cephalochordate species 111 
 5 
[16, 66], which are of particular interest because these invertebrate chordates are the closest 112 
extant relatives of the vertebrates. Furthermore, surveys of neuropeptide diversity have been 113 
reported for the urochordate Ciona intestinalis [32, 45, 71, 73]. Aside from these invertebrate 114 
chordate sub-phyla, three deuterostomian invertebrate phyla are currently recognised: the 115 
echinoderms, the hemichordates and the xenacoelomorphs [8, 9, 64]. A genome-sequencing 116 
project is on going for a hemichordate species [28] but a genome-sequencing project has been 117 
completed for an echinoderm species, the sea urchin Strongylocentrotus purpuratus [74]. 118 
Thus, analysis of neuropeptide genes in this species and in other echinoderm species has the 119 
potential to provide important insights on the evolution of neuropeptides in the 120 
deuterostomian branch of the animal kingdom. 121 
Pioneering studies on neuropeptides in echinoderms detected a peptide in extracts of 122 
starfish nerve cords that triggers gamete maturation and release – “gamete-shedding 123 
substance” or "gonad-stimulating substance" (GSS) [12, 43] However, the molecular identity 124 
of GSS remained unknown for fifty years until it was identified as a relaxin-like peptide in 125 
2009 [59]. Another neuropeptide that triggers gamete maturation and release has been 126 
identified in the sea cucumber Apostichopus japonicus as NGIWYamide, which is structurally 127 
unrelated to relaxin-like GSS in starfish [44]. Interestingly, NGIWYamide was discovered 128 
previously as one of a number of neuropeptides that were identified in Apostichopus on 129 
account of their effects on the contractility of in vitro preparations of body wall muscle and/or 130 
intestine from this species [39, 40]. Furthermore, the protein precursors of NGIWYamide and 131 
other myoactive neuropeptides in Apostichopus have recently been identified by analysis of 132 
transcriptome sequence data [21]. However, the first neuropeptides to be identified in an 133 
echinoderm, the SALMFamides S1 and S2, were isolated on account of their cross-reactivity 134 
with antibodies to the molluscan neuropeptide pQDPFLRFamide [23, 24]. S1 and S2 were 135 
both purified from extracts of radial nerve cords from the starfish species Asterias rubens and 136 
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Asterias forbesi and subsequent studies have revealed that S1, S2 and SALMFamide 137 
neuropeptides identified in other echinoderms act as muscle relaxants [22, 57]. 138 
Sequencing of the Strongylocentrotus purpuratus genome [74] has provided the first 139 
opportunity for a comprehensive analysis of neuropeptide diversity in an echinoderm species. 140 
Identification of thirty-eight genes encoding putative neuropeptide receptors or peptide 141 
hormone receptors [10] indicates that the diversity of neuropeptide signaling pathways in this 142 
echinoderm species is comparable to findings from species belonging to other invertebrate 143 
phyla [34]. However, analysis of the Strongylocentrotus purpuratus genome sequence data 144 
using search strategies such as the Basic Local Alignment Search Tool (tBLASTn; [2]) only 145 
revealed a handful of putative neuropeptide genes. These included a gene encoding seven 146 
putative SALMFamide neuropeptides [26], a gene encoding a vasopressin/oxytocin-type 147 
neuropeptide (“echinotocin”) [25], a gene encoding two copies of a peptide (NGFFFamide) 148 
related to the sea cucumber neuropeptide NGIWYamide [25], three homologs of glycoprotein 149 
hormones (SpGPH1; SpGPH2; SpGPH3 [10]), and two genes encoding homologs of the two 150 
subunits that form the insect neurohormone bursicon [10]. This paucity of putative 151 
neuropeptide genes identified based on BLAST analysis of genome sequence data suggests 152 
that many other neuropeptide genes in Strongylocentrotus purpuratus remain to be discovered 153 
and furthermore that other strategies are needed to identify these genes in the genome. 154 
One strategy that has been successfully employed to identify putative neuropeptides in 155 
Strongylocentrotus purpuratus is the use of mass spectrometry and genomic database 156 
searching to identify and sequence neuropeptides [58]. Here we present a complementary 157 
strategy, namely the analysis of expressed sequence tag (EST) data obtained from a 158 
Strongylocentrotus purpuratus nerve cord cDNA library. We recently demonstrated the utility 159 
of this approach with the identification of a second SALMFamide precursor gene in 160 
Strongylocentrotus purpuratus (Spnp1; [68]) and here we have extended the use of this 161 
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approach with the identification of nineteen other putative neuropeptide precursor genes 162 
(Spnp2 – Spnp20). The data presented here provide novel insights on the evolution of 163 
neuropeptide signaling systems as well as providing a basis for studies in which the 164 
expression and physiological/behavioral roles of neuropeptides are investigated in a model 165 
echinoderm species. 166 
 167 
 168 
 169 
 170 
  171 
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2. Materials and methods 172 
 173 
 The sequences of 2026 expressed sequence tags (ESTs) derived from a 174 
Strongylocentrotus purpuratus radial nerve cDNA library were downloaded from the 175 
National Center for Biotechnology Information (NCBI) EST database (dbEST). These 176 
included 1027 3' reads (GI:109401590 - 109402616) and 999 5' reads (GI:109402617-177 
109403615), all approximately 1000 nucleotides in length. 178 
 To identify transcripts encoding putative neuropeptide precursors the 5’ EST dataset 179 
was first selected for analysis because 5' untranslated regions (UTRs) are typically shorter 180 
than 3' UTRs [63] and therefore 5’ ESTs usually contain more coding sequence than 3’ ESTs. 181 
A recent analysis of RNAseq data has confirmed this for Strongylocentrotus purpuratus, with 182 
an average 5’ UTR length of 269 base pairs and an average 3’ UTR length of 1799 base pairs 183 
[80]. The 5’ ESTs were analysed by submission as queries against the GenBank protein 184 
database using BLASTx and ESTs encoding proteins that were clearly identifiable as 185 
homologs of known proteins that are not neuropeptide precursors were discarded from further 186 
analysis. 187 
A N-terminal signal peptide is required for targeting of neuropeptide precursors to the 188 
lumen of the endoplasmic reticulum as the first step towards the regulated secretory pathway 189 
[75]. Therefore, employing the online signal peptide prediction tool SignalP 190 
(http://www.cbs.dtu.dk/services/SignalP/; [6]), absence of an N-terminal signal peptide 191 
sequence was used as a second criterion for further elimination of ESTs encoding proteins 192 
that are not neuropeptide precursors. 193 
Neuropeptide precursors are typically quite small proteins (e.g. 50-500 residues) and 194 
therefore the length of proteins encoded by ESTs was also used as a criterion for assessment 195 
of potential neuropeptide precursors. Furthermore, more detailed analysis of ESTs encoding 196 
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candidate neuropeptide precursors involved inspection of their primary amino acid sequences 197 
to identify their potential neuropeptide products by searching for the presence of sequences 198 
bounded by potential dibasic (KR, RR, KK, RK) as well as monobasic (R) endopeptidase 199 
cleavage sites [70, 82]. The presence of a glycine residue preceding the putative C-terminal 200 
cleavage site was noted as a potential substrate for C-terminal amidation [20]. Likewise, the 201 
presence of a N-terminal glutamine residue (Q) was noted as a potential substrate for post-202 
translational conversion to a pyroglutamate (pQ) residue [27]. The presence of cysteine 203 
residues was also noted, recognising the potential for the formation of intramolecular or 204 
intermolecular disulphide bridges. 205 
 A subset of ESTs encoding twenty putative neuropeptide precursor proteins was 206 
identified. Full length radial nerve cDNA sequences were obtained, where possible, by 207 
combining 5’ EST sequences with 3’ EST sequence data, which was obtained by submission 208 
of the predicted neuropeptide precursors as BLAST queries against dbEST 209 
(http://www.ncbi.nlm.nih.gov/dbEST/). This BLAST search also enabled identification of 210 
those putative neuropeptide precursors that are also expressed in other adult tissues or in other 211 
development stages in Strongylocentrotus purpuratus. 212 
 Radial nerve cDNA sequences encoding putative neuropeptide precursors were also 213 
subject to further analysis to obtain definitive sequences by comparison with genomic 214 
sequence data using the BLAST facility on SpBase (http://sugp.caltech.edu/SpBase/; [11]). In 215 
particular, the aim here was to correct any EST sequencing errors and also to determine the 216 
exon-intron structure of genes encoding the putative neuropeptide precursors by identification 217 
of 5’ (gt) and 3’ (ag) consensus sites for intron splicing. SpBase was also used to determine if 218 
putative neuropeptide precursors were predicted by the gene prediction tool GLEAN3, which 219 
was used for gene annotation during the annotation phase of the sea urchin genome project 220 
(http://www.hgsc.bcm.tmc.edu/projects/seaurchin; [74]). Likewise, the NCBI sea urchin 221 
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genome resource was used to determine if putative neuropeptide precursors were predicted by 222 
the gene prediction tool Gnomon 223 
(http://www.ncbi.nlm.nih.gov/projects/genome/guide/sea_urchin/). 224 
 Having obtained definitive sequences for the radial nerve cDNAs encoding putative 225 
neuropeptide precursors based on combined EST and genomic sequence data, additional 5’ 226 
and 3’ sequence data was obtained by submission of the radial nerve cDNAs as queries in 227 
BLAST searches of RNAseq data obtained from a variety of sea urchin tissues, including 228 
radial nerve, and available for BLAST analysis on the SpBase website 229 
(http://sugp.caltech.edu/SpBase/rnaseq/; [80]). Thus, the transcript sequences encoding 230 
putative neuropeptide precursors that are shown in the supplementary figures of this paper 231 
include a core sequence based on the original radial nerve EST sequence data (not underlined) 232 
with additional 5’ and 3’ sequences obtained from RNAseq data underlined.  233 
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3. Results and Discussion 234 
 235 
We report here the identification of twenty putative neuropeptide precursors in the sea 236 
urchin Strongylocentrotus purpuratus. The strategy employed involved analysis of the 237 
sequences of 2026 ESTs derived from a radial nerve cDNA library, complementing a 238 
previous study that used mass spectrometric analysis of radial nerve extracts with reference to 239 
the Strongylocentrotus purpuratus genome sequence [58]. Analysis of the radial nerve EST 240 
dataset revealed cDNAs encoding two neuropeptide precursors that were originally 241 
discovered by analysis of genomic sequence data using BLAST: the F-type SALMFamide 242 
precursor [26] and the NGFFFamide precursor [25]. These findings demonstrated that known 243 
neuropeptide precursors are represented amongst the collection of 2026 radial nerve ESTs 244 
analysed, providing an important indication that more detailed scrutiny of the EST dataset 245 
might reveal additional neuropeptide precursors. The first novel neuropeptide precursor 246 
identified by analysis of the EST dataset was the L-type SALMFamide precursor reported 247 
previously [68], which we have designated as “Strongylocentrotus purpuratus neuropeptide 248 
precursor 1” or Spnp1 (Fig. 1 and Fig. S1). Here we report the discovery of a further nineteen 249 
putative neuropeptide precursors, which we have designated Spnp2 – Spnp20. The sequences 250 
of these precursor proteins are shown in Fig. 1 and Fig. 2, whilst in supplementary figures S1 251 
– S20 the cDNA sequences are included together with their translated protein products. A 252 
detailed description and discussion of Spnp2 – Spnp20 is presented below. 253 
 254 
3.1. Spnp2 (SpGNRHP): precursor of a gonadotropin-releasing hormone-type peptide 255 
Spnp2 is a 131-residue protein comprising a predicted 30-residue N-terminal signal 256 
peptide followed by a gonadotropin-releasing hormone (GnRH)-like neuropeptide (SpGnRH) 257 
with the predicted sequence pyroGlu-Val-His-His-Arg-Phe-Ser-Gly-Trp-Arg-Pro-Gly-NH2 258 
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(Fig. 1). The N-terminal pyroGlu residue and the C-terminal amide group are predicted based 259 
on the occurrence of these post-translational modifications in GnRH-type peptides identified 260 
in other species and the existence of this GnRH-type peptide in Strongylocentrotus 261 
purpuratus has been reported previously [67]. 262 
The protein sequence of Spnp2 (SpGnRH precursor or SpGnRHP) was initially 263 
identified by analysis of the sequences of the radial nerve cDNAs RNSP-1M3 (5': 264 
EC439573.1, GI:109403596, 3': EC438289.1, GI:109402312), RNSP-1D2 (5': EC439527.1, 265 
GI:109403550, 3': EC428144.1, GI:109402167), RNSP-1N3 (5': EC439440.1, GI:109403463, 266 
3': EC438444.1, GI:109402467), RNSP-9I7 (5': EC439133.1, GI:109403156) and RNSP-267 
1G17 (5': EC439418.1, GI:109403441, 3': EC438392.1, GI:109402415). However, a cDNA 268 
encoding Spnp2 is also represented in a larval cDNA library (MPMGp691D2380, 5': 269 
CD294893.1, GI:34745970, 3': EC437745.1, GI:109401768). Furthermore, Spnp2 was 270 
predicted from automated analysis of genomic sequence data by gene prediction tools 271 
(Gnomon - GI:72011734; GLEAN3_19680) and assigned the gene ID number SPU_019680 272 
[74]. The Spnp2 cDNA sequence shown in Fig. S2 is a consensus sequence derived from 273 
genomic, cDNA/EST and RNAseq (WHL22.157157.0) sequence data. 274 
GnRH was originally discovered in mammals on account of its stimulatory effect on 275 
the release from the anterior pituitary of the gonadotropins luteinizing hormone (LH) and 276 
follicle-stimulating hormone (FSH) [69]. Subsequently, GnRH-type peptides have been 277 
identified in other vertebrates [46] and in invertebrates, including molluscs [41], annelids [84] 278 
and urochordates [31, 79]. Furthermore, adipokinetic hormone (AKH) – type peptides are 279 
homologs of GnRH found in arthropods and nematodes [49, 50]. Thus, the discovery of a 280 
gene encoding a GnRH-like peptide in Strongylocentrotus purpuratus was to be expected 281 
because the GnRH neuropeptide family has a widespread phylogenetic distribution in the 282 
animal kingdom. However, SpGnRH is the first member of the GnRH neuropeptide family to 283 
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be identified in an echinoderm. The existence of SpGnRH in Strongylocentrotus purpuratus 284 
has recently been reported independently as part of a broad analysis of the evolution of the 285 
GnRH neuropeptide family [67]. Roch et al. (2011) compared the sequence of SpGnRH with 286 
the sequences of identified or putative GnRH-type peptides in a wide range of animal phyla, 287 
highlighting similarities with GnRH-type peptides in vertebrates, invertebrate chordates and 288 
other invertebrate phyla.  289 
The protein-coding region of the SpGnRH gene comprises three exons with the signal 290 
peptide and SpGnRH peptide encoded by the first exon (Fig. S2), a feature that is shared with 291 
the human GnRH gene and GnRH genes in other vertebrates. The presence of single copy of 292 
the GnRH peptide is a feature of all known GnRH-type precursors, although the vertebrate 293 
precursors include a C-terminal gonadotropin-associated peptide (GAP) region containing a 294 
52 residue protein of unknown function. The SpGnRH precursor also contains an 85 residue 295 
C-terminal sequence, which spans all three exons, but which lacks sequence homology to 296 
vertebrate GAP. 297 
           It is of interest to consider the potential physiological roles of SpGnRH in sea urchins. 298 
A recurring theme for GnRH-type neuropeptides throughout the animal kingdom is a role in 299 
regulation of reproductive processes. For example, GnRH-immunoreactivity is present in a 300 
nerve plexus that innervates the gonads and gonoducts of the urochordate Ciona intestinalis 301 
[52] and GnRH-type peptides stimulate gamete release in Ciona [76]. Furthermore, in the 302 
nematode C. elegans RNAi-mediated knockdown of genes encoding a GnRH/AKH-type 303 
peptide or a GnRH-type receptor delays egg-laying [50]. Investigation of the physiological 304 
roles of SpGnRH in sea urchins would be facilitated by identification of the receptor(s) that 305 
mediate effects of this peptide. Candidate receptors are proteins that share sequence similarity 306 
with the G-protein coupled GnRH-type receptors (GnRHRs) that have been identified in 307 
vertebrates and other invertebrates [67]. Relevant in this regard are genes encoding three 308 
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GnRHR-like proteins in Strongylocentrotus purpuratus -  SpGnRHR1 (GI:185134933; 309 
SPU_001536), SpGnRHR2 (GI:185134985; SPU_001537); and SpGNRHR3 (GI:185134947; 310 
SPU_001531). Characterisation of the ligand-binding properties of these proteins and analysis 311 
of their tissue/organ expression profiles in Strongylocentrotus purpuratus may facilitate 312 
investigation of the physiological roles of SpGnRH in sea urchins. 313 
 314 
3.2. Spnp3 (SpTRHLP): precursor of a thyrotropin-releasing hormone-like peptide 315 
 Spnp3 is a 316-residue precursor protein comprising a predicted 15-residue N-316 
terminal signal peptide and nineteen putative neuropeptides bounded by monobasic or dibasic 317 
cleavage sites (Fig. 1). These include ten copies of the sequence QYPGG, four copies of the 318 
sequence QWPGG and single copies of the sequences QFPAG, QFPGG, QFVGGELIPSPEL, 319 
QWPEV and QFVGGEALEQESNIN. The presence of a N-terminal glutamine (Q) residue 320 
and a C-terminal glycine (G) residue in the majority of these sequences are indicative of post-321 
translational modifications giving rise to a N-terminal pyroglutamate residue (pQ) and C-322 
terminal amide group. For example, the most abundant of the putative neuropeptide sequences 323 
(QYPGG) would give rise to mature peptides with the structure pGlu-Tyr-Pro-Gly-NH2. This 324 
peptide is noteworthy because it shares structural similarity with human thyrotropin-releasing 325 
hormone (TRH, pGlu-His-Pro-NH2). Therefore, we refer to Spnp3 as SpTRH-like precursor 326 
(SpTRHLP) and we refer to the most abundant of its putative constituent peptides (pGlu-Tyr-327 
Pro-Gly-NH2) as SpTRH. 328 
 The protein sequence of Spnp3 was initially identified by analysis of the sequences of 329 
the radial nerve cDNA RNSP-9P21 (5': EC438846.1, GI:109402869, 3': EC437745.1, GI: 330 
109401768). However, a cDNA encoding Spnp3 is also represented in a primary 331 
mesenchyme cell cDNA library (PMCSPR2-184H11, 5': DN579827.1  GI:61138866). 332 
Furthermore, Spnp3 was predicted from automated analysis of genomic sequence data by 333 
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gene prediction tools (Gnomon - GI:185134999; GLEAN3_08352) and assigned the gene ID 334 
number SPU_008352 [74]. The Spnp3 cDNA sequence shown in Fig. S3 is a consensus 335 
sequence derived from genomic, cDNA/EST and also RNAseq (WHL22.3018.0) sequence 336 
data. 337 
 Thyrotropin-releasing hormone (TRH; pGlu-His-Pro-NH2) is a hypothalamic hormone 338 
that stimulates release of thyroid stimulating hormone (TSH) and prolactin from the anterior 339 
pituitary. In humans and most mammals, six copies of TRH are derived from the TRH 340 
precursor protein, whereas in non-mammalian vertebrates eight copies of TRH appears to be 341 
the norm [85]. Although TRH-like immunoreactivity has been detected in a crustacean 342 
species [37], to the best of our knowledge TRH-like peptides have not been identified in any 343 
invertebrate species. 344 
 Spnp3 encodes a 316-residue protein comprising ten copies of the sequence QYPGG, 345 
which shares structural similarity with TRH. Thus, with post-translational conversion of the 346 
N-terminal glutamine residue to pyroglutamate and use of the C-terminal glycine as a 347 
substrate for amidation, a peptide would be formed (pGlu-Tyr-Pro-Gly-NH2; SpTRH) that has 348 
a pGlu-X-Pro motif, as found in TRH. The peptide pGlu-Tyr-Pro-Gly-NH2 also shares C-349 
terminal sequence similarity with SpGnRH (pGlu-Val-His-His-Arg-Phe-Ser-Gly-Trp-Arg-350 
Pro-Gly-NH2) and other GnRH-type peptides. However, the sea urchin peptide and is more 351 
similar to TRH than GnRH both in terms of its length (four residues) and the existence of 352 
multiple copies of the peptide in its precursor. Nevertheless, the similarity with GnRH is 353 
intriguing and it may perhaps indicate that TRH-type peptides originated from a GnRH-type 354 
peptide. SpTRHLP is the first putative precursor of a TRH-like peptide to be discovered in an 355 
invertebrate species, indicating that the origins of the TRH-type peptides may date back at 356 
least as far as the common ancestor of deuterostomes. 357 
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Investigation of the physiological roles of SpTRH in sea urchin would be facilitated 358 
by identification of the receptor that this putative peptide binds to.  In mammals TRH exerts 359 
effects by binding to a G-protein coupled TRH receptor and a gene encoding a protein that is 360 
closely related to mammalian TRH receptors has been identified in Strongylocentrotus 361 
purpuratus (SPU_010167; [10]). Therefore, SPU_010167 is a candidate mediator of the 362 
effects of the SpTRH peptide in sea urchins. Interestingly, whilst TRH-like peptides have thus 363 
far only been found in vertebrates, TRH receptor-like proteins have been identified in 364 
protostomian invertebrates. For example, the Drosophila gene CG2114 encodes an ortholog 365 
of vertebrate TRH receptors and the endogenous ligands for this receptor are FMRFamide-366 
type neuropeptides [56]. Thus, TRH-type receptors date back to the common ancestor of the 367 
bilateria and it appears that amidated short peptides have evolved as endogenous ligands for 368 
these receptors in different branches of the animal kingdom. Therefore, it will be interesting 369 
to determine if the putative amidated tetrapeptide, SpTRH (pGlu-Tyr-Pro-Gly-NH2), is indeed 370 
the endogenous ligand for the TRH receptor-like protein (SPU_010167) in sea urchins. 371 
 372 
3.3. Spnp4 (SpCTLPP): precursor of a calcitonin-like peptide 373 
 Spnp4 is a 110-residue protein comprising a predicted 21-residue N-terminal signal 374 
peptide and, bounded by dibasic cleavage sites, a 38-residue peptide that shares structural 375 
similarity with calcitonin and calcitonin-like peptides (Fig. 1). The C-terminal residue of the 376 
38-residue peptide is a glycine residue, which is a potential substrate for C-terminal 377 
amidation. Thus, Spnp4 is predicted to give rise to a 37-residue peptide with the sequence 378 
SKGCGSFSGCMQMEVAKNRVAALLRNSNAHLFGLNGP-NH2, which we refer to as 379 
Strongylocentrotus purpuratus calcitonin-like peptide (SpCTLP). 380 
 The protein sequence of Spnp4 was initially identified by analysis of the sequences of 381 
the radial nerve cDNAs RNSP-9A2 (5': EC438671.1, GI:109402694, 3': EC437655.1, 382 
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GI:109401678), RNSP-5C1 (5': EC439006.1, GI:109403029, 3': EC438242.1, GI:109402265), 383 
RNSP-5H24 (5': EC439062.1, GI:109403085; 3': EC437612.1, GI:109401635), RNSP-9I12 384 
(5': EC438743.1, GI:109402766, 3': EC437839.1, GI:109401862), RNSP-5P22 (5': 385 
EC439097.1, GI:109403120, 3': EC437635.1, GI:109401658), RNSP-9M18 (5': EC438785.1, 386 
GI:109402808, 3': EC437878.1, GI:109401901) and RNSP-9K20 (5': EC438638.1, 387 
GI:109402661, 3': EC437888.1, GI:109401911). However, cDNAs encoding Spnp4 are also 388 
represented in a larval cDNA library (MPMGp691H2032, 5': CD309678.1, GI:34754727, 389 
MPMGp691H16126, CD307674.1, GI:34752723). Furthermore, Spnp4 was predicted from 390 
automated analysis of genomic sequence data by gene prediction tool Gnomon 391 
(GI:115767208). The Spnp4 cDNA sequence shown in Fig. S4 is a consensus sequence 392 
derived from genomic and cDNA/EST sequence data. 393 
In mammals calcitonin is released from parafollicular cells of the thyroid gland and 394 
inhibits Ca2+ absorption by the intestines and osteoclast activity in bones [87]. Calcitonin is 395 
encoded by a gene that also encodes calcitonin-gene related peptide (CGRP), with alternative 396 
splicing of transcripts giving rise to either prepro-calcitonin (exons 1, 2, 3 and 4) or prepro-397 
CGRP (exons 1, 2, 3, 5 and 6) [3]. By way of comparison, the Spnp4 has five exons, the fifth 398 
of which encodes SpCTLP peptide sequence (Figure S4).    399 
A characteristic that SpCTLP shares with both calcitonin and CGRP is the presence of 400 
two cysteine residues in the N-terminal region of the peptide (residues 4 and 10 in SpCTLP) 401 
(Fig. 3). In calcitonin and CGRP these cysteine residues form a disulphide bridge and it seems 402 
likely, therefore, that this is also a feature of SpCTLP. At the C-terminus of SpCTLP is a 403 
putative Pro-amide motif and in this respect SpCTLP is more like calcitonin than CGRP (see 404 
Fig. 3). 405 
Calcitonin/CGRP-like peptides have been identified throughout the vertebrates [62] 406 
but relatively little is known about the occurrence and characteristics of calcitonin/CGRP-type 407 
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peptides in invertebrates. A key finding was the discovery that a diuretic hormone (DH31) 408 
identified in the cockroach Diploptera punctate is structurally related to calcitonin [30] 409 
providing important molecular evidence that calcitonin/CGRP-type peptides may have a 410 
widespread phylogenetic distribution in the animal kingdom. However, DH31-type peptides 411 
identified in Diploptera punctate and in other insects do not have the two cysteines that are a 412 
feature of the N-terminal region of calcitonin/CGRP-type peptides in vertebrates. Recently a 413 
calcitonin-like peptide (Ci-CT) was identified in the sea-squirt Ciona intestinalis (Phylum 414 
Chordata) and this peptide does have two cysteine residues in its N-terminal region, which 415 
indicated that this feature may be a unique characteristic of calcitonin/CGRP-type peptides in 416 
chordates [72]. It is of interest, therefore, that the calcitonin-like peptide identified here in the 417 
sea urchin Strongylocentrotus purpuratus (SpCTLP) also has two cysteine residues, which are 418 
located at positions 4 and 10 (Fig. 3). This suggests that this feature of calcitonin/CGRP-type 419 
peptides in vertebrates can in fact be traced back beyond the chordates to the common 420 
ancestor of extant deuterostomes. 421 
As SpCTLP is the first calcitonin-like peptide to be discovered in an echinoderm it 422 
will be interesting to investigate its physiological roles. Opportunities to do this would be 423 
facilitated by identification of its receptor. In mammals, calcitonin exerts effects by binding to 424 
a G-protein coupled receptor that belongs to secretin-type family of receptors. A homolog of 425 
mammalian calcitonin/CGRP-type receptors is present in Strongylocentrotus purpuratus 426 
(SPU_018314; Burke et al. 2006) and therefore this is a likely candidate as the receptor for 427 
SpCTLP. 428 
 429 
3.4. Spnp5 (SpANPP): precursor of a family of peptides with a N-terminal Ala-Asn motif – the 430 
AN peptides 431 
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Spnp5 is a 441-residue protein that comprises a 27-residue signal peptide and thirteen 432 
copies of putative neuropeptides that are structurally related, all having an N-terminal 433 
dipeptide sequence Ala-Asn (AN) (Fig. 1). Therefore, we have designated these as 434 
Strongylocentrotus purpuratus AN peptides or SpANPs and we refer to Spnp5 as 435 
Strongylocentrotus purpuratus AN peptide precursor (SpANPP). Spnp5 contains one copy of 436 
the sequence ANYFRGRGRKPG (SpANP1), eight copies of the sequence 437 
ANMFRSRLRGKG (SpANP2), two copies of the sequence ANMFRSRLRGNG (SpANP3), 438 
one copy of the sequence ANYFRGRGRRPG (SpANP4) and one copy of the sequence 439 
ANFRARQRPKLGK (SpANP5). It is noteworthy that all of these AN peptide sequences 440 
except ANP5 have a C-terminal glycine residue, which is a potential substrate for C-terminal 441 
amidation. Other structural characteristics are shared amongst some but not all of the putative 442 
neuropeptides. 443 
The protein sequence of Spnp5 (SpANPP) was initially identified by analysis of the 444 
sequences of the radial nerve cDNAs RNSP-5B16 (5': EC438945.1, GI:109402968, 3': 445 
EC438118.1, GI:109402141), RNSP-5K1 (5': EC438975.1, 109402998, 3': EC438249.1, 446 
GI:109402272), RNSP-9G19 (5': EC438680.1, GI:109402703, 3': EC437567.1, 447 
GI:109401590), RNSP-9M16 (5': EC438692.1, GI: 109402715, 3': EC437817.1, 448 
GI:109401840), RNSP-5O19 (5': EC439324.1, GI:109403347, 3': EC438561.1, 449 
GI:109402584) and RNSP-5G14 (5': EC439381.1, GI:109403404, 3': EC438026.1, GI: 450 
109402049). Interestingly, however, a cDNA encoding Spnp5 is also represented amongst 451 
cDNAs from bacterially activated coelomocytes (CK829173.1, GI:50873844). Automated 452 
analysis of genomic sequence data with gene prediction tools produced conflicting data with 453 
respect to Spnp5. The GLEAN3 method predicted that the 441 residues of Spnp5 form the C-454 
terminal region of a much larger protein comprising 2208 residues (GLEAN3_18666), which 455 
was named Sp-Zcchc11 on account of its zinc finger motifs and a CCHC domain and was 456 
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assigned the gene ID number SPU_018666 [74]. On the other hand the Gnomon gene 457 
prediction method predicts a 441-residue protein that is identical to Spnp5 (SpANPP). 458 
Importantly, both EST and RNAseq data confirm the existence of transcripts that encode the 459 
441-residue Spnp5 (SpANPP) protein and therefore we can conclude that the Gnomon gene 460 
prediction was correct and the GLEAN3 gene prediction was incorrect. Thus, the Spnp5 461 
cDNA sequence shown in Fig. S5 is a consensus sequence derived from genomic, cDNA/EST 462 
and also RNAseq (WHL22.164432.1) sequence data. 463 
 Mass spectroscopic analysis has confirmed that three of the peptides predicted to be 464 
derived from SpANPP, SpANP1, SpANP2 and SpANP3, are present in nerve cords from 465 
Strongylocentrotus purpuratus and are C-terminally amidated [58]. Furthermore, we have 466 
independently confirmed the presence of SpANP2 in extracts of tests from Strongylocentrotus 467 
purpuratus (M.L. Rowe, R.D. Burke and M.R. Elphick, unpublished data). We have not 468 
identified any striking sequence similarities that AN peptides share with neuropeptides 469 
identified in other phyla. Thus, there are no comparative perspectives on potential 470 
physiological roles of these neuropeptides in sea urchins. Furthermore, preliminary 471 
pharmacological studies testing synthetic SpANP2 for myoactivity in sea urchins did not 472 
reveal effects on the contractile activity of tube foot or oesophagus preparations (M.L. Rowe 473 
and M.R. Elphick, unpublished data). Therefore, further studies are now required to 474 
investigate the physiological roles of AN peptides in sea urchins. 475 
 476 
3.5. Spnp6 (SpPPLNP1) and Spnp7 (SpPPLNP2): precursors of peptides related to molluscan 477 
pedal peptides and arthropod orcokinins. 478 
Both Spnp6 and Spnp7 contain putative neuropeptides that share sequence similarity 479 
with pedal peptide (PLDSVYGTHGMSGFA), a neuropeptide originally isolated from the 480 
mollusc Aplysia californica [51]. Therefore we refer to Spnp6 as Strongylocentrotus 481 
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purpuratus pedal peptide-like neuropeptide precursor 1 (SpPPLNP1) and we refer to Spnp7 482 
as Strongylocentrotus purpuratus pedal peptide-like neuropeptide precursor 2 (SpPPLNP2) 483 
Spnp6 (SpPPLNP1) is a 510-residue protein (Fig. 1) comprising a 29-residue N-484 
terminal signal peptide and 21 copies of pedal peptide-like neuropeptides: SpPPLN1a 485 
(RFLTGALEPLSSGFI; 1 copy), SpPPLN1b (GFNTGAMEPLGSGFI; 2 copies), SpPPLN1c 486 
(GFNSGAMEPLGAGFF; 8 copies), SpPPLN1d (GFNSGAMEPLGSGFI; 5 copies), 487 
SpPPLN1e (GFNNGAMEPLGSGFI; 1 copy), SpPPLN1f (DFNTGAMEPLGSGFI; 1 copy), 488 
SpPPLN1g (GFHAGAMEPLSSGFIDG; 1 copy), SpPPLN1h (GFYNGAMEPLSAGFHQG; 489 
1 copy) and SpPPLN1i (GFHNGAMEPLKSGFLKD; 1 copy). 490 
 The protein sequence of Spnp6 (SpPPLNP1) was initially identified by analysis of the 491 
sequences of the radial nerve cDNA RNSP-9E2 (5': EC438675.1, GI:109402698, 3': 492 
EC437660.1, GI: 109401683). However, cDNAs encoding Spnp6 are also represented in 493 
blastula cDNA libraries (MPI_537_46L9, 5': CD332062.1, GI:34798584, 3': CD324334.1, 494 
GI: 34796395; yda51d10, 5': CX558302.1, GI:57585331; yda83f08, 5': CX554074.1, 495 
GI:57581103), a primary mesenchyme cell cDNA library (PMCSPR2-101N6, 5': 496 
DN788099.1, GI:62376892, 3': DN564330.1, GI: 61123369), a gastrula cDNA library 497 
(MPI_536_18H7, 5': CD339652.1, GI:34806178) and a lantern cDNA library (LSP-2M22, 5': 498 
EC435043.1, GI:109399066, 3': EC430111.1, GI: 109394134). Furthermore, Spnp6 was 499 
predicted from automated analysis of genomic sequence data by gene prediction tools 500 
(Gnomon - GI:72008820; GLEAN3_03108) and assigned the gene ID number SPU_003108 501 
[74]. The Spnp6 cDNA sequence shown in Fig. S6 is a consensus sequence derived from 502 
genomic, cDNA/EST and also RNAseq (WHL22.633184) sequence data. 503 
Spnp7 (SpPPLNP2) is a 204-residue protein comprising a putative 19-residue N-504 
terminal signal peptide and ten putative neuropeptides: SpPPLN2a (FGSMNMEPLVSGFY), 505 
SpPPLN2b (FGSGLDSMQSGFY), SpPPLN2c (NFGSGLNMEPMQSGFY), SpPPLN2d 506 
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(NFGGSMEPMQSGFY), SpPPLN2e (FGGAMEPMSSGFY), SpPPLN2f 507 
(FGSGSLEPMSSGFY; 2 copies), SpPPLN2g (NFGGSLEPMQSGFY), SpPPLN2h 508 
(FGGANEPMRSGFF) and SpPPLN2i (NFGGSLDAMQSGFY). 509 
The protein sequence of Spnp7 was initially identified by analysis of the sequences of 510 
the radial nerve cDNA RNSP-5B10 (5': EC439068.1, GI:109403091, 3': EC438075.1, 511 
GI:109402098). However, a larval cDNA/EST encoding Spnp7 (MPMGp691F1380, 5': 512 
CD294941.1, GI:34746018, 3': CD309924.1, GI: 34754973) has also been deposited in the 513 
GenBank database. Furthermore, Spnp7 was also predicted from automated analysis of 514 
genomic sequence data using gene prediction tools (Gnomon - GI:390352582; 515 
GLEAN3_24381) and was assigned the gene ID number SPU_024381 [74]. Thus, the Spnp7 516 
cDNA sequence shown in Fig. S7 is a consensus sequence derived from genomic, cDNA/EST 517 
and also RNAseq (WHL22.656375.0) sequence data. 518 
 Pedal peptide was originally isolated from the mollusc Aplysia californica and was 519 
named pedal peptide because it is predominantly synthesised in pedal ganglia of the Aplysia 520 
central nervous system [51]. Subsequently, the sequence of a precursor protein (pedal peptide 521 
1 precursor) from which pedal peptide is derived has been determined [60], revealing that it 522 
contains 17 copies of the peptide originally isolated by Lloyd and Connolly [51] as well as 523 
two other structurally related peptides. Furthermore, in Aplysia there are three other 524 
precursors containing peptides related to pedal peptide and these are known as pedal peptide 2 525 
precursor, pedal peptide 3 precursor and pedal peptide 4 precursor [60]. In Figure 4, the 526 
sequences of representative peptides derived from SpPPLNP1 (PPLN1d) and from 527 
SpPPLNP2 (PPLN2h) are aligned with the prototypical Aplysia pedal peptide and 528 
representative peptides derived from pedal peptide 2 precursor and pedal peptide 3 precursor. 529 
Both PPLN1d and PPLN2h share a C-terminal SGFX (where X is a hydrophobic residue) 530 
motif with pedal peptide but otherwise the level of sequence identity is quite low. However, 531 
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the sea urchin and Aplysia peptides have similar characteristics with respect to the number of 532 
residues and distribution of hydrophobic and hydrophilic residues. Furthermore, like 533 
SpPPLNP1 and SpPPLNP2 (see Fig. 1), the Aplysia pedal peptide-type precursors comprise 534 
many copies of the constituent peptides [60]. Importantly, when SpPPLNP1 is submitted as a 535 
BLAST query against the GenBank protein database it is the Aplysia pedal peptide 2 536 
precursor that is the next best hit after SpPPLNP2. Collectively, these findings suggest that 537 
SpPPLNP1 and SpPPLNP2 share a common evolutionary ancestry with the Aplysia pedal 538 
peptide-type precursors.     539 
Discovery of SpPPLNP1 and SpPPLNP2 is of particular interest because these are the 540 
first pedal peptide-type neuropeptide precursors to be discovered in a deuterostomian 541 
invertebrate. Thus, the existence of pedal peptide-type neuropeptide precursors in a 542 
protostomian invertebrate (the mollusc Aplysia californica) and a deuterostomian invertebrate 543 
(the echinoderm Strongylocentrotus purpuratus) suggests that the origins of pedal peptide-544 
type neuropeptides may trace back at least as far as the common ancestor of bilaterian 545 
animals. Therefore, the existence of pedal peptide-type neuropeptide precursors in other 546 
protostomian and deuterostomian animal phyla would be expected. Consistent with this 547 
notion, genes encoding pedal peptide-like precursor proteins have been identified in the 548 
annelid species Capitella teleta, Helobdella robusta and Platynereis dumerilii [14, 84] and a 549 
representative pedal peptide-type neuropeptide from Platynereis dumerilii is included in the 550 
alignment in Fig. 4. Surprisingly, however, there are no reports in the literature of pedal 551 
peptide-type precursors in ecdysozoan protostomes such as arthropods and nematodes, which 552 
could of course reflect loss of pedal peptide-type genes in the ecdysozoan lineage. However, 553 
because our discovery of SpPPLNP1 and SpPPLNP2 has revealed that pedal peptide-type 554 
precursors are not restricted to lophotrochozoan phyla (e.g. molluscs and annelids), we have 555 
investigated the occurrence of pedal peptide-type precursors in nematodes and arthropods. 556 
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Interestingly, we have identified pedal peptide-type precursors in the nematode 557 
Caenorhabditis elegans (NLP14; GI:392926792 and NLP15; GI:7498042). Furthermore, 558 
submission of these Caenorhabditis pedal peptide-type precursors as BLAST queries against 559 
the GenBank protein database reveals that they share significant similarity with molluscan 560 
pedal peptide precursors and also with precursors of orcokinin-type neuropeptides in several 561 
arthropod species. This suggests that orcokinins and pedal peptide-type neuropeptides may be 562 
members of a bilaterian family of homologous neuropeptides. Accordingly, the sequences of 563 
orcokinin peptides from the crustacean Procambrus clarkii and the insect Nasonia vitripennis 564 
are also included in the alignment shown in Figure 4. 565 
 Discovery of SpPPLNP1 and SpPPLNP2 has provided a basis for investigation of the 566 
physiological roles of pedal peptide-type neuropeptides in the sea urchin Strongylocentrotus 567 
purpuratus. Moreover, because our findings indicate that pedal peptide/orcokinin-type 568 
neuropeptides may occur throughout the bilateria, it will be of particular interest to compare 569 
the functions of these peptides in protostomian and deuterostomian invertebrates. 570 
 Progress towards functional studies on peptides derived from SpPPLNP1 and 571 
SpPPLNP2 has been facilitated by mass spectroscopic analysis of Strongylocentrotus 572 
purpuratus [58]. Thus, mass spectrometry has confirmed the presence in nerve extracts of 573 
eight of the peptides (SpPPLN1a – SpPPLN1h) predicted to be derived from SpPPLNP1 and 574 
has also revealed that the C-terminal glycine residue of SpPPLN1g and SpPPLN1h is a 575 
substrate for amidation - GFHAGAMEPLSSGFIDamide and 576 
GFYNGAMEPLSAGFHQamide, respectively. Interestingly, a peptide corresponding to a C-577 
terminally truncated form of SpPPLN1i that lacks the last two residues of the predicted 578 
peptide (i.e. GFHNGAMEPLKSGFL as opposed to GFHNGAMEPLKSGFLKD) was 579 
detected in nerve extracts, which may indicate an unusual utilisation of lysine (K) as a 580 
monobasic cleavage site. Mass spectrometry has also confirmed the presence in nerve extracts 581 
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of six of the nine peptides predicted to be derived from SpPPLNP2 (SpPPLN2a, SpPPLN2b, 582 
SpPPLN2c, SpPPLN2d, SpPPLN2f and SpPPLN2h) [58]. 583 
 Using HPLC-MS we have independently confirmed the presence of SpPPLN1c 584 
(GFNSGAMEPLGAGFF) in extracts of tests from Strongylocentrotus purpuratus (M.L. 585 
Rowe, R.D. Burke and M.R. Elphick, unpublished data). We have also tested synthetic 586 
SpPPLN1c for myoactivity on sea urchin tube foot or oesophagus preparations, but no effects 587 
were observed (M.L. Rowe and M.R. Elphick, unpublished data). Therefore, as with AN 588 
peptides, further studies are now required to investigate the physiological roles of PPLN1- 589 
and PPLN2-type neuropeptides in sea urchins. 590 
 591 
3.6. Spnp8 592 
Spnp8 is a 85-residue protein comprising a predicted 22-residue N-terminal signal 593 
peptide followed by a 63-residue sequence (residues 23-85) that contains a putative dibasic 594 
cleavage site (KR) at residues 55 and 56 (Fig. 1). The C-terminal region of the protein 595 
(residues 57-85) contains six acidic residues (D or E), indicating that this part of the protein 596 
functions as an acidic spacer peptide. On this basis we propose that it is the 32-residue 597 
polypeptide formed by residues 23-54 that may be a secreted bioactive neuropeptide. 598 
However, residues 23-54 also include a potential monobasic cleavage site (R), so there 599 
remains the possibility that the polypeptide formed by residues 23-54 is cleaved into two 600 
smaller bioactive neuropeptides. 601 
The protein sequence of Spnp8 was initially identified by analysis of the sequences of 602 
the 27 radial nerve cDNAs: RNSP-1H1 (5': EC439462.1; GI:109403485, 3: EC438486.1, 603 
GI:109402509), RNSP-9M8 (5': EC438717.1, GI:109402740, 3': EC437865.1, 604 
GI:109401888), RNSP-1B10 (5': EC438982.1, GI:109403005, 3': EC438229.1, 605 
GI:109402252), RNSP-1G3 (5': EC439570.1, GI:109403593, 3': EC438336.1, 606 
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GI:109402359), RNSP-1E5 (5': EC439589.1, GI:109403612; 3': EC438296.1, GI:109402319), 607 
RNSP-1K10 (5': EC439419.1, GI:109403442, 3': EC438388.1, GI:109402411), RNSP-9H4 608 
(5' EC438985.1, GI:109403008, 3': EC437792.1, GI:109401815), RNSP-9D1 (5': 609 
EC438727.1, GI:109402750, 3': EC437872.1, GI:109401895), RNSP-9D6 (5': EC438965.1, 610 
GI:109402988, 3': EC437772.1, GI:109401795), RNSP-1L3 (5': EC439437.1, GI:109403460, 611 
3': EC438443.1, GI:109402466), RNSP-1K1 (5': EC439577.1, GI:109403600, 3': 612 
EC438315.1, GI:109402338), RNSP-9J15 (5': EC438756.1, GI:109402779, 3': EC437782.1, 613 
GI:109401805), RNSP-5E14 (5': EC439380.1, GI:109403403, 3': EC438958.1, 614 
GI:109402981), RNSP-9J21 (5': EC438839.1, GI:109402862, 3': EC437742.1, 615 
GI:109401765), RNSP-9A15 (5': EC438948.1, GI:109402971, 3': EC437598.1, 616 
GI:109401621), RNSP-1D1 (5': EC439459.1, GI:109403482, 3': EC438485.1, 617 
GI:109402508), RNSP-1D12 (5': EC438880.1, GI:109402903, 3': EC438199.1, 618 
GI:109402222), RNSP-5G20 (5': EC439365.1, GI:109403388, 3': EC438529.1, 619 
GI:109402552), RNSP-5K20 (5': EC439155.1, GI:109403178, 3': EC437663.1, 620 
GI:109401686), RNSP-5I6 (5': EC439250.1, GI:109403273, 3': EC437904.1, GI:109401927), 621 
RNSP-5L9 (5': EC438910.1, GI:109402933, 3': EC437976.1, GI:109401999), RNSP-5C12 622 
(5': EC439201.1, GI:109403224, 3': EC437986.1, GI:109402009), RNSP-5I22 (5': 623 
EC439245.1, GI:109403268, 3': EC437910.1, GI:109401933), RNSP-1I3 (5': EC439571, 624 
GI:109403594), RNSP-9G12 (5': EC438741.1, GI:109402764, 3':EC437837.1, 625 
GI:109401860), RNSP-9P11(5': EC438781.1, GI:109402804, 3':EC437795.1, GI:109401818), 626 
RNSP-5G17 (5': EC439347, GI:109403370). This large number of radial nerve cDNAs 627 
encoding Spnp8 suggests that it is expressed at a high level in the adult nervous system. 628 
However, cDNAs encoding Spnp8 are also represented amongst cDNAs from larvae 629 
(MPMGp691F1913; 5': CD295824, GI:34746901) and primary mesenchyme cells 630 
(PMCSPR2-127I19; 5': DN790471.1, GI:62380538, 3': DN563688.1, GI:61122727). 631 
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Spnp8 was predicted from genome sequence data by the gene prediction tool Gnomon 632 
(XP_001175942.1, GI:115764725). It was not predicted, however, by the GLEAN3 tool that 633 
was used for genome annotation [74] and therefore it has as yet not been assigned a gene ID 634 
number. The Spnp8 cDNA sequence shown in Fig. S8 is a consensus sequence derived from 635 
genomic and cDNA/EST sequence data. 636 
The putative 32-residue neuropeptide derived from Spnp8 does not share any apparent 637 
sequence similarity with neuropeptides or peptide hormones identified in other phyla.  638 
 639 
3.7. Spnp9 640 
Spnp9 is a 97-residue protein comprising a predicted 18-residue N-terminal signal 641 
peptide followed by a 79-residue sequence (residues 19-97) that contains a putative dibasic 642 
cleavage site (KR) at residues 42 and 43 (Fig. 1). The C-terminal region of the protein 643 
(residues 44-97) contains nine acidic residues (D or E), indicating that this part of the protein 644 
may function as an acidic spacer peptide. On this basis we propose that it is the 23-residue 645 
polypeptide formed by residues 19-41 that may be a secreted bioactive neuropeptide. 646 
However, residues 19-41 also include two potential monobasic cleavage sites (R), so there 647 
remains the possibility that the polypeptide formed by residues 19-41 is cleaved into two or 648 
three smaller bioactive neuropeptides. The C-terminal residue of the polypeptide sequence 649 
formed by residues 19-41 is glycine, which may be a substrate for amidation. 650 
 The protein sequence of Spnp9 was initially identified by analysis of the sequences of 651 
the radial nerve cDNAs RNSP-5J5 (3': EC437977.1, GI:109402000), RNSP-9A13 (5': 652 
EC439000.1, GI:109403023, 3': EC437636.1, GI:109401659), RNSP-9O3 (5': 653 
EC438941.1, GI:109402964, 3': EC437709.1, GI:109401732). However, cDNAs encoding 654 
Spnp9 are also represented amongst cDNAs from larvae (MPMGp691E2327, 5': 655 
CD305936.1, GI:34750985), blastulae (yda60d12, 5': CX559052.1, GI:57586081; 656 
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yde01d12, 5': CX698100.1, GI:57960911; ydd37h11, 5': CX691973.1, GI:57954046; 657 
ydc90e11, 5': CX694141.1, GI:57956476; yda10h10, 5': CX079346.1, GI:56593336; 658 
yda48h06, 5': CX199608.1, GI:56847032; ydc58c11, 5': CX681794.1, GI:57942445; 659 
yde84e05, 5': CX692690.1, GI:57954849 and primary mesenchyme cells 660 
(91222952_F24_086_PC_0025_A1_MR_C12, 5': BG780665.1, GI:14151678). 661 
 Spnp9 was not predicted from automated analysis of genomic sequence data by the 662 
gene prediction tools Gnomon and GLEAN3 and therefore Spnp9 has not been assigned a 663 
gene ID number. The Spnp9 cDNA sequence shown in Fig. S9 is a consensus sequence 664 
derived from genomic and cDNA/EST sequence data. 665 
If the 23-residue putative neuropeptide derived from Spnp9 is amidated, then the C-666 
terminal region of the peptide (HGMPFamide) shares sequence similarity with members of 667 
the SALMFamide neuropeptide family (e.g. AYQTGLPFamide, an L-type SALMFamide 668 
neuropeptide in the starfish Marthasterias glacialis [92]). This relatively low level of 669 
sequence similarity may of course reflect convergent molecular evolution. Furthermore, a C-670 
terminal Phe-amide motif is a common feature of many types of neuropeptides [65] and 671 
further studies are now required to investigate the relationship of the putative Spnp9-derived 672 
neuropeptide and peptides with a C-terminal Phe-amide motif that have been identified in 673 
other animals. 674 
 675 
3.8. Spnp10 676 
Spnp10 is a 100-residue protein comprising a predicted 24-residue N-terminal signal 677 
peptide followed by a 76-residue sequence (residues 25-100) that contains putative dibasic 678 
cleavage sites (KR) at residues 59/60 and 91/92 (Fig. 2). The N-terminal region of the protein 679 
(residues 25-58) contains ten acidic residues (D or E), indicating that this part of the protein 680 
may function as an acidic spacer peptide. On this basis we propose that it is the 30-residue 681 
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polypeptide formed by residues 61-90 that may be a secreted bioactive neuropeptide. 682 
However, residues 61-90 also include three potential monobasic cleavage sites (R), so there 683 
remains the possibility that the polypeptide formed by residues 61-90 is cleaved into two or 684 
more smaller bioactive neuropeptides. The C-terminal residue (90) of the polypeptide is 685 
glycine, which may be a substrate for amidation. 686 
 The protein sequence of Spnp10 was identified by analysis of the sequences of the 687 
radial nerve cDNAs RNSP-5C3 (5': EC439329.1, GI:109403352, 3': EC438259.1, 688 
GI:109402282), RNSP-1M1 (5': EC439578.1, GI:109403601, 3': EC438318.1, 689 
GI:109402341) and RNSP-5A23 (5': EC439390.1, GI:109403413, 3': EC438559.1, 690 
GI:109402582) but Spnp10 was not found to be represented in other cDNA libraries.  691 
Spnp10 was predicted from genome sequence data by the gene prediction tool 692 
Gnomon (XP_001178130.1, GI:115647054). It was not predicted, however, by the GLEAN3 693 
tool that was used for genome annotation [74] and therefore it has as yet not been assigned a 694 
gene ID number. The Spnp10 cDNA sequence shown in Fig. S10 is a consensus sequence 695 
derived from genomic and cDNA/EST sequence data. 696 
If the C-terminal glycine of the 30-residue neuropeptide derived from Spnp10 is a 697 
substrate for amidation, then the mature Spnp10-derived neuropeptide would be a 29-residue 698 
peptide with a C-terminal Ser-amide motif. However, this peptide does not share any apparent 699 
sequence similarity with neuropeptides or peptide hormones identified in other phyla.  700 
 701 
3.9. Spnp11 702 
Spnp11 is a 103-residue protein comprising a predicted 21-residue N-terminal signal 703 
peptide followed by a 82-residue sequence (residues 22-103) that contains a putative dibasic 704 
cleavage site (KR) at residues 48 and 49 (Fig. 2). The N-terminal region of the protein 705 
(residues 22-47) contains seven acidic residues (D or E), indicating that this part of the protein 706 
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may function as an acidic spacer peptide. We propose that it is the 54-residue polypeptide 707 
formed by residues 50-103 that may be a secreted bioactive neuropeptide. It is noteworthy 708 
that the 54-residue sequence includes six cysteine residues located at positions 57, 61, 64, 75, 709 
79 and 95 because this suggests the presence of up to three potential disulphide bridges that 710 
would confer tertiary structure on the polypeptide. Alternatively a homodimeric protein could 711 
be formed by up to six intermolecular disulphide bridges. It should also be noted, however, 712 
that the 54 residue sequence also includes two potential monobasic cleavage sites (R), so 713 
there remains the possibility that the polypeptide formed by residues 50-103 is cleaved into 714 
two or more smaller bioactive neuropeptides. 715 
The protein sequence of Spnp11 was identified by analysis of the sequences of the 716 
radial nerve cDNAs RNSP-9C11 (5': EC439009.1, GI:109403032, 3': EC437677.1, 717 
GI:109401700), RNSP-9C20 (5': EC438791.1, GI:109402814, 3': EC437882.1, 718 
GI:109401905) but Spnp11 was not found to be represented in other cDNA libraries. Spnp11 719 
was predicted from genome sequence data by the gene prediction tool Gnomon 720 
(XP_001175484.1, GI:115666438). It was not predicted, however, by the GLEAN3 tool that 721 
was used for genome annotation [74] and therefore it has as yet not been assigned a gene ID 722 
number. The Spnp11 cDNA sequence shown in Fig. S11 is a consensus sequence derived 723 
from genomic and cDNA/EST sequence data. 724 
The putative fifty-four residue neuropeptide derived from Spnp11 does not exhibit any 725 
apparent primary amino acid sequence similarity with neuropeptides identified in other 726 
animals. However, neuropeptides of a similar size and with six cysteine residues have been 727 
identified in other animals. For example, molt-inhibiting hormone (MIH) is a seventy-eight 728 
residue neuropeptide in the crustacean Carcinus maenas with six cysteine residues that form 729 
three intramolecular disulphide bonds [86]. 730 
 731 
 31 
3.10. Spnp12 732 
Spnp12 is a 104-residue protein comprising a predicted 25-residue N-terminal signal 733 
peptide followed by a 79-residue sequence (residues 26-104) that contains a putative dibasic 734 
cleavage site (KR) at residues 41 and 42 (Fig. 2). The C-terminal region of the protein 735 
(residues 43-104) contains eleven acidic residues (D or E), indicating that this part of the 736 
protein may function as an acidic spacer peptide. We propose that it is the 15-residue peptide 737 
(HNTFSFKGRSRYFPG) formed by residues 26-40 that may be a secreted bioactive 738 
neuropeptide. The presence of a C-terminal glycine residue suggests that this peptide may be 739 
amidated at the C-terminus. However, the 15-residue peptide sequence contains two potential 740 
monobasic cleavage sites (R), so there remains the possibility that the peptide formed by 741 
residues 26-40 is cleaved into two or more smaller bioactive neuropeptides. 742 
The protein sequence of Spnp12 was identified by analysis of the sequence of the 743 
radial nerve cDNA RNSP-1D20 (5': EC439240.1, GI:109403263, 3': EC438177.1, 744 
GI:109402200). However, a cDNA encoding Spnp11 is also represented amongst cDNAs 745 
from larvae (MPMGp691I24108, 5': CD297038.1, GI:34748115). Spnp12 was predicted 746 
from genome sequence data by the gene prediction tool Gnomon (XP_001178129.1  747 
GI:115620334) but Spnp12 was not, however, predicted by GLEAN3 [74] and therefore it 748 
was not assigned a gene ID number during genome annotation. The Spnp12 cDNA sequence 749 
shown in Fig. S12 is a consensus sequence derived from genomic and cDNA/EST sequence 750 
data. 751 
The putative C-terminally amidated 14-residue peptide derived from Spnp12 does not 752 
share any apparent sequence similarity with neuropeptides or peptide hormones identified in 753 
other phyla. 754 
 755 
3.11. Spnp13 756 
 32 
Spnp13 is a 102-residue protein comprising a predicted 18-residue N-terminal signal 757 
peptide and the putative neuropeptide LPANLARE (residues 19-26), which is bounded C-758 
terminally by a putative dibasic cleavage site (RR) (Fig. 2). There are no other dibasic sites 759 
from residue 29 to 102, but there are potential monobasic sites (R) in this part of the protein 760 
so it is possible that other neuropeptides are derived from Spnp13. It is also noteworthy that 761 
there are nine acidic residues (D or E) in the C-terminal region of the protein from residue 64 762 
to 102, indicating that this part of the protein may function as an acidic spacer peptide. 763 
The protein sequence of Spnp13 was identified by analysis of the sequence of the 764 
radial nerve cDNAs RNSP-1N21 (5': EC439560.1, GI:109403583, 3': EC438178.1, 765 
GI:109402201) and RNSP-1O7 (5': EC439274.1, GI:109403297, 3': EC438582.1, GI: 766 
109402605) but Spnp13 was not found to be represented in other cDNA libraries. Spnp13 767 
was predicted from genome sequence data by the gene prediction tool Gnomon 768 
(XP_001176371.1, GI:115660734) but Spnp13 was not, however, predicted by GLEAN3 769 
[74] and therefore it was not assigned a gene ID number during genome annotation. The 770 
Spnp13 cDNA sequence shown in Fig. S13 is a consensus sequence derived from genomic 771 
and cDNA/EST sequence data. 772 
Importantly, the existence of the putative neuropeptide derived from Spnp13 773 
(LPANLARE) has been confirmed by mass spectrometric analysis of nerve extracts from 774 
Strongylocentrotus purpuratus [58]. However, this peptide does not share any apparent 775 
sequence similarity with neuropeptides or peptide hormones identified in other phyla. 776 
 777 
3.12. Spnp14 778 
Spnp14 is a 113-residue protein comprising a predicted 26-residue N-terminal signal 779 
peptide followed by a 87-residue sequence (residues 27-113) that contains a putative dibasic 780 
cleavage site (KR) at residues 85 and 86 (Fig. 2). The N-terminal region of the protein 781 
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(residues 27-84) contains ten acidic residues (D or E), indicating that this part of the protein 782 
may function as an acidic spacer peptide. We propose that it is the 27-residue peptide 783 
(SRSGRKLRFCMDVIRNTWRLCRNTRSN) formed by residues 87-113 that may be a 784 
secreted bioactive neuropeptide. The presence of two cysteine residues (underlined above) 785 
suggests the presence of a disulphide bridge. Alternatively a homodimeric protein could be 786 
formed by up to two intermolecular disulphide bridges. 787 
The protein sequence of Spnp14 was identified by analysis of the sequence of the 788 
radial nerve cDNA RNSP-9C12 (5': EC438737.1, GI:109402760, 3': EC437833.1, 789 
GI:109401856) but Spnp14 was not found to be represented in other cDNA libraries. Spnp14 790 
was predicted from genome sequence data by the gene prediction tool Gnomon 791 
(XP_001179912.1, GI:115958765) but Spnp14 was not, however, predicted by GLEAN3 792 
[74] and therefore it was not assigned a gene ID number during genome annotation. The 793 
Spnp14 cDNA sequence shown in Fig. S14 is a consensus sequence derived from genomic 794 
and cDNA/EST sequence data. 795 
The putative twenty-seven residue neuropeptide derived from Spnp14 does not exhibit 796 
any apparent primary amino acid sequence similarity with neuropeptides identified in other 797 
animals. However, neuropeptides with two cysteine residues have been identified in other 798 
animals. For example, the neurohypophyseal hormones vasopressin and oxytocin have two 799 
cysteine residues, which form a single intramolecular disulphide bond [19]. 800 
 801 
3.13. Spnp15 802 
Spnp15 is a 115-residue protein comprising a predicted 22-residue N-terminal signal 803 
peptide followed by a 93-residue sequence (residues 23-115) that contains a putative dibasic 804 
cleavage site (RR) at residues 74 and 75 (Fig. 2). The N-terminal region of the protein 805 
(residues 23-73) contains fourteen acidic residues (D or E), indicating that this part of the 806 
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protein may function as an acidic spacer peptide. We propose that it is the 40-residue peptide 807 
formed by residues 74-115 that may be a secreted bioactive neuropeptide. The presence of six 808 
cysteine residues in the 40-residue polypeptide suggests that there may be up to three 809 
intramolecular disulphide bridges. Alternatively a homodimeric protein could be formed by 810 
up to six intermolecular disulphide bridges. 811 
The protein sequence of Spnp15 was identified by analysis of the sequence of the 812 
radial nerve cDNAs RNSP-9F4 (5': EC439029.1, GI:109403052, 3': EC437791.1, GI: 813 
109401814), RNSP-9O10 (5': EC438734.1, GI:109402757, 3': EC437829.1, GI:109401852) 814 
and RNSP-5A10 (5': EC439227.1, GI:109403250, 3': EC438016.1, GI:109402039) but 815 
Spnp15 was not found to be represented in other cDNA libraries. Spnp15 was predicted from 816 
genome sequence data by the gene prediction tool Gnomon (XP_001175507.1, 817 
GI:115920974) but Spnp15 was not, however, predicted by GLEAN3 [74] and therefore it 818 
was not assigned a gene ID number during genome annotation. The Spnp15 cDNA sequence 819 
shown in Fig. S15 is a consensus sequence derived from genomic and cDNA/EST sequence 820 
data. 821 
The putative forty-residue neuropeptide derived from Spnp11 does not exhibit any 822 
apparent primary amino acid sequence similarity with neuropeptides identified in other 823 
animals. However, neuropeptides of a similar size and with six cysteine residues have been 824 
identified in other animals. For example, trissin is a twenty eight-residue neuropeptide in 825 
Drosophila melanogaster with six cysteine residues that form three intramolecular disulphide 826 
bonds [38]. 827 
 828 
3.14. Spnp16 829 
Spnp16 is a 119-residue protein comprising a predicted 20-residue N-terminal signal 830 
peptide followed by a 99-residue sequence (residues 21-119) that contains a putative dibasic 831 
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cleavage site (KR) at residues 94 and 95 (Fig. 2). The N-terminal region of the protein 832 
(residues 21-93) contains seventeen acidic residues (D or E), indicating that this part of the 833 
protein may function as an acidic spacer peptide. We propose that it is the 24-residue peptide 834 
(GRRPARKICINDIWKGRGGGLRCN) formed by residues 96-119 that may be a secreted 835 
bioactive neuropeptide. The presence of two cysteine residues (underlined above) suggests the 836 
presence of an intramolecular disulphide bridge or alternatively two intermolecular disulphide 837 
bridges could form a homodimeric construct. 838 
 The protein sequence of Spnp16 was identified by analysis of the sequence of the 839 
radial nerve cDNAs RNSP-1O8 (5': EC439410.1, GI:109403433, 3': EC438414.1, 840 
GI:109402437) and RNSP-1P22 (5': EC439044.1, GI:109403067; 3': EC438269 841 
GI:109402292) but Spnp16 was not found to be represented in other cDNA libraries. Spnp16 842 
was predicted from genome sequence data by the gene prediction tool Gnomon 843 
(XP_001176809.1, GI:115898497) but Spnp16 was not, however, predicted by GLEAN3 [74] 844 
and therefore it was not assigned a gene ID number during genome annotation. The Spnp16 845 
cDNA sequence shown in Fig. S16 is a consensus sequence derived from genomic and 846 
cDNA/EST sequence data. 847 
 The putative twenty four-residue neuropeptide derived from Spnp16 does not 848 
exhibit any apparent primary amino acid sequence similarity with neuropeptides identified in 849 
other animals. However, as highlighted above for Spnp14, neuropeptides with two cysteine 850 
residues that form a single intramolecular disulphide bond have been identified in other 851 
animals (e.g. vasopressin and oxytocin [19]). 852 
 853 
3.16. Spnp17 854 
Spnp17 is a 120-residue protein comprising a predicted 24-residue N-terminal signal 855 
peptide followed by a 96-residue sequence (residues 25-120) that contains putative dibasic 856 
 36 
cleavage sites at residues 88/89 (RR) and 96/97 (RR) (Fig. 2). However, the neuropeptide 857 
products of this protein are difficult to predict. If the arginine residue at position 49 is used as 858 
a monobasic cleavage site, a peptide 859 
(SVLKLMKYEILLKLMNDLCDELDMCPPSQVPARQAPVV) with two cysteine residues 860 
(underlined) would be liberated, with the potential for an intramolecular disulphide bridge or 861 
alternatively two intermolecular disulphide bridges giving rise to a homodimeric construct. A 862 
potential second neuropeptide (RGGAHLFWRTGVLNKSPIMKAAN) could be liberated 863 
from the protein if the dibasic cleavage site at residues 96/97 is used. It is noteworthy that in 864 
the N-terminal part of the protein following the signal peptide (residues 25-61) there are seven 865 
acidic residues (D or E), indicating that this part of the protein may function as an acidic 866 
spacer peptide. 867 
 The protein sequence of Spnp17 was identified by analysis of the sequence of the 868 
radial nerve cDNA RNSP-5E13 (5': EC439292.1, GI:109403315, 3': EC438502.1  869 
GI:109402525) but Spnp17 was also found to be represented in a lantern cDNA library (LSP-870 
2M15, 5': EC435368.1, GI:109399391). Spnp17 was not predicted from genome sequence 871 
data by the gene prediction tools Gnomon or GLEAN3 and therefore it was not assigned a 872 
gene ID number during genome annotation [74]. The Spnp17 cDNA sequence shown in Fig. 873 
S17 is a consensus sequence derived from genomic and cDNA/EST sequence data. 874 
 The putative neuropeptides derived from Spnp17 do not exhibit any apparent 875 
primary amino acid sequence similarity with neuropeptides identified in other animals. 876 
 877 
3.17. Spnp18 878 
Spnp18 is a 121-residue protein comprising a predicted 24-residue N-terminal signal 879 
peptide followed by a 97-residue sequence (residues 25-121) that contains putative dibasic 880 
cleavage sites (KR) at residues 38/39 and 110/111 (Fig. 2). We propose that it is the 70-881 
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residue polypeptide formed by residues 40-109 that may be a secreted bioactive neuropeptide. 882 
It is noteworthy that this putative 70-residue neuropeptide contains eight cysteine residues, 883 
which may form up to four intramolecular disulphide bridges. Alternatively, up to eight 884 
intermolecular disulphide bridges may give rise to dimeric constructs of the polypeptide. 885 
The protein sequence of Spnp18 was identified by analysis of the sequence of the 886 
radial nerve cDNAs RNSP-1M16 (5': EC439524.1, GI:109403547, 3': EC438421.1, 887 
GI:109402444), RNSP-1O1 (5': EC439579.1, GI:109403602, 3': EC438322.1, 888 
GI:109402345), RNSP-9M3 (5': EC438932.1, GI:109402955, 3': EC437708.1, 889 
GI:109401731), RNSP-1A12 (5': EC439372.1, GI:109403395; 3': EC438395.1, 890 
GI:109402418), RNSP-1E15 (5': EC439205.1, GI:109403228, 3': EC438375.1, 891 
GI:109402398), RNSP-1I12 (5': EC439376.1, GI:109403399, 3': EC438367.1, 892 
GI:109402390) and RNSP-9L6 (5': EC438939.1, GI:109402962, 3': EC437751.1, 893 
GI:109401774). Spnp18 was not represented in other cDNA libraries. Spnp18 was predicted 894 
from genome sequence data by the gene prediction tool Gnomon (XP_001175944.1, 895 
GI:115839524) but Spnp18 was not, however, predicted by GLEAN3 [74] and therefore it 896 
was not assigned a gene ID number during genome annotation. The Spnp18 cDNA sequence 897 
shown in Fig. S18 is a consensus sequence derived from genomic and cDNA/EST sequence 898 
data. 899 
The putative seventy-residue neuropeptide derived from Spnp18 does not exhibit any 900 
apparent primary amino acid sequence similarity with neuropeptides identified in other 901 
animals, which would be indicative of a common evolutionary relationship. However, 902 
neuropeptides of a similar size and with eight cysteine residues have been identified in other 903 
animals. For example, schistosomin is a seventy-nine residue anti-gonadotropic peptide in the 904 
pond snail Lymnaea stagnalis and it has eight cysteine residue that are thought to form four 905 
intramolecular disulphide bonds [36]. 906 
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 907 
3.18. Spnp19 908 
Spnp19 is a 129-residue protein comprising a predicted 22-residue N-terminal signal 909 
peptide followed by a 107-residue sequence (residues 23-129) that contains putative dibasic 910 
cleavage sites (KR) at residues 55/56 and 122/123 (Fig. 2). We propose that it is the 65-911 
residue polypeptide formed by residues 57-121 that may be a secreted bioactive neuropeptide. 912 
It is noteworthy that this putative 65-residue neuropeptide contains two cysteine residues 913 
(positions 54 and 65 in the putative peptide), which may form an intramolecular disulphide 914 
bridge. Alternatively, two intermolecular disulphide bridges may give rise to dimeric 915 
constructs of the polypeptide. 916 
The protein sequence of Spnp19 was identified by analysis of the sequence of the 917 
radial nerve cDNA RNSP-9F9 (5': EC438819.1, GI:109402842, 3': EC437908.1, 918 
GI:109401931) and was not represented in other cDNA libraries. Spnp19 was predicted from 919 
genome sequence data by the gene prediction tool Gnomon (XP_001176669.1, 920 
GI:115722995) but Spnp19 was not, however, predicted by GLEAN3 [74] and therefore it 921 
was not assigned a gene ID number during genome annotation. The Spnp19 cDNA sequence 922 
shown in Fig. S19 is a consensus sequence derived from genomic and cDNA/EST sequence 923 
data. 924 
The putative sixty five-residue neuropeptide derived from Spnp16 does not exhibit 925 
any apparent primary amino acid sequence similarity with neuropeptides identified in other 926 
animals. 927 
 928 
3.19. Spnp20 929 
Spnp20 is a 157-residue protein comprising a predicted 22-residue N-terminal signal 930 
peptide followed by a 135-residue sequence (residues 23-157) that contains a putative dibasic 931 
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cleavage site (RR) at residues 112/113 (Fig. 2). We propose that it is the 44-residue 932 
polypeptide formed by residues 114-157 that may be a secreted bioactive neuropeptide. It is 933 
noteworthy that this putative 44-residue neuropeptide contains two cysteine residues 934 
(positions 18 and 24 in the putative peptide), which may form an intramolecular disulphide 935 
bridge. Alternatively, two intermolecular disulphide bridges may give rise to dimeric 936 
constructs of the polypeptide. 937 
The protein sequence of Spnp20 was identified by analysis of the sequence of the 938 
radial nerve cDNA RNSP-1I6 (5': EC439447.1, GI:109403470, 3': EC438404.1, 939 
GI:109402427) but it is also represented in many other cDNA libraries, including unfertilised 940 
egg (e.g. MPMGp621P0242, 5': CD316932.1, GI:34788993), 7 hour cleavage stage (e.g. 941 
CALTp538D011, 5': CD319009.1, GI:34791070, 3': CD290037.1, GI:34741114), 20 hour 942 
blastula stage (e.g. CALTp537G0419, 5': CD336553.1, GI:34803079, 3': CD324544.1, 943 
GI:34796605), primary mesenchyme cells (e.g. PMCSPR2-160F9, 5': DN585364.1, 944 
GI:61235578, 3': DN568702.1, GI:61127741) and larvae (e.g. MPMGp691B14106, 5': 945 
CD307438.1, GI:34752487). Spnp20 was predicted from automated analysis of genomic 946 
sequence data by gene prediction tools (Gnomon - XP_799788.2, GI:390348447; 947 
GLEAN3_14142) and assigned the gene ID number SPU_014142 [74]. The Spnp20 cDNA 948 
sequence shown in Fig. S20 is a consensus sequence derived from genomic, cDNA/EST and 949 
also RNAseq (WHL22.545917.1) sequence data. 950 
The putative forty four-residue neuropeptide derived from Spnp20 does not exhibit 951 
any apparent primary amino acid sequence similarity with neuropeptides identified in other 952 
animals.   953 
 954 
4.8. Conclusions 955 
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 The identification of precursor proteins for putative neuropeptides in the sea urchin 956 
Strongylocentrotus purpuratus, as reported here, is of interest from two perspectives. 957 
Firstly, it contributes to a growing body of comparative data on neuropeptides, 958 
providing new insights on the phylogenetic distribution and evolutionary origins of 959 
neuropeptide families in the animal kingdom. For example, an important finding from this 960 
study is the discovery that calcitonin-like peptides with two N-terminally located cysteine 961 
residues are found not only in chordates but also in a non-chordate deuterostome and 962 
therefore the origin of this type of peptide can be traced back to the common ancestor of 963 
extant deuterostomes. Additionally, the discovery of pedal peptide-like neuropeptides in 964 
Strongylocentrotus purpuratus has revealed a bilaterian family of pedal peptide/orcokinin-965 
type neuropeptides. 966 
Secondly, discovery of twenty putative neuropeptide precursors provides a solid 967 
foundation for a comprehensive investigation of neuropeptide function in a model 968 
echinoderm. There are many fascinating aspects of echinoderm biology, including remarkable 969 
powers of regeneration [78] following autotomy of body parts [88] and the “mutability” of 970 
echinoderm connective tissue [89]. There is evidence that neuropeptides are important 971 
regulators of these and many other aspects of echinoderm biology [7, 22] and the putative 972 
neuropeptides identified here in Strongylocentrotus purpuratus provide material for 973 
experimental studies on sea urchins. Moreover, Strongylocentrotus purpuratus is first and 974 
foremost a model system for development biology [55] and the neuropeptide precursors 975 
identified here provide material for developmental analysis of neuropeptide expression and 976 
function and analysis of the organisation of neuropeptide systems in the simple nervous 977 
system of the free-swimming larval stage of this species.  978 
  979 
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Figure legends 989 
 990 
Figure 1. 991 
Amino acid sequences of the Strongylocentrotus purpuratus putative neuropeptide precursors 992 
Spnp1 – Spnp9. The predicted N-terminal signal peptide for each precursor is shown in bold 993 
lettering. Putative neuropeptides are shown in white with black highlighting, with the 994 
exception of cysteine residues, which are shown in white with light grey highlighting. C-995 
terminal glycine residues that are putative substrates for amidation are shown in white with 996 
dark grey highlighting. Putative cleavage sites are shown with black letters and light grey 997 
highlighting. 998 
 999 
Figure 2. 1000 
Amino acid sequences of the Strongylocentrotus purpuratus putative neuropeptide precursors 1001 
Spnp10 – Spnp20. The predicted N-terminal signal peptide for each precursor is shown in 1002 
bold lettering. Putative neuropeptides are shown in white with black highlighting, with the 1003 
exception of cysteine residues, which are shown in white with light grey highlighting. C-1004 
terminal glycine residues that are putative substrates for amidation are shown in white with 1005 
dark grey highlighting. Putative cleavage sites are shown with black letters and light grey 1006 
highlighting. 1007 
 1008 
Figure 3. 1009 
Sequence alignment of the Strongylocentrotus purpuratus calcitonin-like peptide (SpCTLP) 1010 
with human calcitonin, human calcitonin gene-related peptide (CGRP), Ciona calcitonin (Ci 1011 
CT), Drosophila calcitonin-like diuretic peptide (DH 31), and Homarus calcitonin-like 1012 
diuretic peptide (DH 31). Cysteine residues are shown in white with black highlighting, the 1013 
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basic amino acids Lys and Arg are shown in black with light grey highlighting and the acidic 1014 
residues Glu and Asp are shown in black with dark grey highlighting. All other amino acids 1015 
are classified as hydrophobic (white with light grey highlighting) or hydrophilic (white with 1016 
dark grey highlighting). C-terminal amide groups are shown as a lowercase “a”. Note that 1017 
SpCTLP has two cysteine residues in its N-terminal region, a character that it shares with 1018 
human calcitonin, human CGRP and Ciona CT but not with calcitonin-like diuretic peptides 1019 
in arthropods (Drosophila DH 31 and Homarus DH31). Therefore, this may be a conserved 1020 
and characteristic feature of calcitonin-type peptides in deuterostomes. References: 1. 1021 
GI:179820, 2. GI:76880478, 3. GI:283046319, 4. This paper, 5. GI:17647327, 6. GI: 1022 
260594183 [13]  1023 
 1024 
Figure 4. 1025 
Sequence alignment of Strongylocentrotus purpuratus pedal peptide-like neuropeptides 1026 
SpPPLN1d and SpPPLN2h with pedal peptides from the mollusc Aplysia californica, a pedal 1027 
peptide-like neuropeptide derived from the “FDSIG” precursor in the annelid Platynereis 1028 
dumerilii, orcokinin-type neuropeptides in the crustacean Procambrus clarkii and the insect 1029 
Nasonia vitripennis and pedal peptide/orcokinin-like peptides derived from the NPL14 and 1030 
NPL15 precursor proteins in Caenorhabditis elegans. The basic amino acids Lys and Arg are 1031 
shown in black with light grey highlighting and the acidic residues Glu and Asp are shown in 1032 
black with dark grey highlighting. All other amino acids are classified as hydrophobic (white 1033 
with light grey highlighting) or hydrophilic (white with dark grey highlighting). References: 1034 
1. This paper, 2. GI:325297152, GI: 325296771, GI: 325296775 [60]. 3. GI: 332167919 [14], 1035 
4. GI:392926792, GI:7498042, 5. GI:38258254 [90], 6. GI: 345489156.  1036 
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Spnp1 (L-type SALMFamide)  
MQVQQITVFLVACTLSVLVVAYAQEDAETVLLNRLRDIAARAAAGELPDFFADVDDYKRGGKKNMG
SIHSHSGIHFGKRRDSESSERARNTKRMRLHPGLLFGKRAPVQKWDQWQAQDTYNPDWELGQFN 
 
Spnp2 (SpGnRHP) 
MKQIITSLVSISAALLLFVLISEYTPRCNGQVHHRFSGWRPGGKKRSDAAEVNSNKITIERPQLPI
CQTTEERQLLEGDSDILGDLRRAANRMRLLQLFNLSKTRLNDLNDATSNEVDERPVYGDYLGTGL 
 
Spnp3 (SpTRHLP)  
MWACILGYVTWGGAALPTILGKELVLSENDGPEIADWVQGKEIPLRNQYWGDVAEEEEEEELGMLS
PDSEKRQYPGGKRQYPGGKRQYPGGKRQYPGGKRQFPAGKRQFVGGELIPSPELRQWPGGKRQWPG
GKRQWPGGKRQYPGGKRQYPGGKRQWPEVKRQYPGGKRSEDDQDLLPMEIRQYPGGKRQWPGGKRQ
YPGGKRQYPGGKRQFPGGKRQFVGGEALEQESNINKRFAPEDDTMDFFRLSQLYDTNDNIVADEGE
LALEDLLDDIMVDTRPEFEDPRDLLLGNVDQEDVLALDLSALLGDRNPNNGW 
 
Spnp4 (SpCTLPP) 
MKSTVIVTLTICCLLYQTTRAASLTNRDGLSRQDILDLLQLYEEPIRQEGGDKRSKGCGSFSGCMQ
MEVAKNRVAALLRNSNAHLFGLNGPGKRRRSVDDLPQVNDAETE 
 
Spnp5 (SpANPP) 
MSRNAYLWAGLLLGALCLLITTTSIKADGEVTEDVDKRANYFRGRGRKPGKRDEPDAALVPDDDLS
EDKRANMFRSRLRGKGKRDDPDAAMLPGDWDEEKRANMFRSRLRGNGKRDDPDAAMLPGDWDEEKR
ANMFRSRLRGKGKRDEPDAAEALVPGDWEEEKRANMFRSRLRGKGKRDDPDAAEALVPGDDLSEEK
RANMFRSRLRGKGKRDDPDAAEALVPGDDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGGDLSE
EKRANMFRSRLRGKGKRDDPDAAEALVPGGDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGDWD
EEKRANMFRSRLRGKGKRDDPDAALVGDDFGDEFVDEEKRANMFRSRLRGNGKRDDPDAALVDEFM
DEEKRANYFRGRGRRPGKRDEPDAALVEDEKRANFRARQRPKLGK 
 
Spnp6 (SpPPLNP1) 
MKFSGNGRGAFLVVNLIFVLCLVDHMAECRPARKTRDVDEDLEKEEDSLINALEKVLADEEVIDNA
ENDSDDETGITDRELSLMLSMLRDDVSPSRLRGYFGGKWRPAYYPSESLHVGALEPLATGFLPSRY
SGQKKRFLTGALEPLSSGFIKKGFNTGAMEPLGSGFIKKGFNSGAMEPLGAGFFKKGFNSGAMEPL
GAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAME
PLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKGFNNGA
MEPLGSGFIKKGFNSGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKGFNTGAMEPLGSGFIKKGFNS
GAMEPLGSGFIKKDFNTGAMEPLGSGFIKKGFNSGAMEPLGAGFFKKGFHAGAMEPLSSGFIDGKR
GFYNGAMEPLSAGFHQGKRGFHEGEMDKDKKGFHNGAMEPLKSGFLKD 
 
Spnp7 (SpPPLNP2) 
MNNYAFLFCLACAIGQVWTLPIEDKDGLDIEDQEEAEKRFGSMNMEPLVSGFYKRFGSGLDSMQSG
FYKKNFGSGLNMEPMQSGFYKKNFGGSMEPMQSGFYKRFGGAMEPMSSGFYKRFGSGSLEPMSSGF
YKKNFGGSLEPMQSGFYKRFGGANEPMRSGFFKRFGSGSLEPMSSGFYKKNFGGSLDAMQSGFYKR
SQEETD 
 
Spnp8 
MANRQLLALAFIVSLALAVVEARNFHAAMGGPRPWQAGMKQQSALPDKGTNPFLKRLKQIVFQPDG
FYDPGMDHFAFGEAFNADE 
 
Spnp9 
MRSSLAVLLLACLAAIISRESPVQAVPRIRPAILQHGMPFGKRGYSGNNARDCFHRALNDDKNSEE
LVNLIEAWYRMKVEDGLSCMNGLSAFDEAAA 
  
Figure 1
Spnp10 
MKSVYQVVLAFLAVLVCVAWTCQAYGLDQDEYRRGAAENALDEQEIYEIIESLEHAMSKRGSVKHL
GLANVDNWRMMKNVNRLRNLLNSGKRSDQQLDSQ 
 
Spnp11 
MNSLILVVMGLLLLTAELIPAAPAPYFDEDAMDLMDPVFNFKDDSAVKRSPMLQKSCIYTCLACSK
NTQMTMPECIYGCQSAGRDPSQARAYNACHKYLHSGR 
 
Spnp12 
MDSNMTVRSLVILSVLLLAVVSCHAHNTFSFKGRSRYFPGKRAITDGSAVDTASQRFESINLDDFQ
KPESQLTLREMLTELRGYCDFLLKLLDGVRPDLPQQRK 
 
Spnp13  
MELRLFLLVVLFCALATSLPANLARERRTTNPVLRDKGRESMKTKQFRIGYRYGRAWQPPTTLDDN
VYGADNYDNEAFQFRNLPLLEKLIAQLEKADENGGY 
 
Spnp14 
MEPHQLTLTVFILSLSVLMAVTSTGAFPQEVRGDRTGHMIDGFSNDIDLLPLQETALIRLLSNLQS
SSSEYASGEDETYPMVASKRSRSGRKLRFCMDVIRNTWRLCRNTRSN 
 
Spnp15  
MNTLSQYLLLICSLLVFIQSYALPTYDKQNVDELQGDNDIDEQQLEMWDAMQGGDNDDVFSRLTRG
GEAFSRDRRRVCVSDCSFCHSFFPTYKLGNCFHGCRKGFHDLGCKQFRY 
 
Spnp16  
MNLTTCYLAILAAILAVAAGRTLDLGLPVMELQEEDFPQMQEQNMEHQSMRDMVSARLWSIIQRLK
MDQAVDLKDELDTLDQGAEKMLSEDFNKRGRRPARKICINDIWKGRGGGLRCN 
 
Spnp17  
MNSTISTLLSLAALLIIAVQMSSALSITEGPQGGSAWALEDNEEPVDYRSVLKLMKYEILLKLMND
LCDELDMCPPSQVPARQAPVVRRGDNNQERRRGGAHLFWRTGVLNKSPIMKAAN 
 
Spnp18 
MQPNSIISVAVVMTLATLFTQAVCSLQFETTQDRVPAKRLFWVDKKDHPVDTDFFTVRANDAEEVL
DCFVEVCIADFVNCAKKCLFYENGNTCLPTCRHTRSICSVQCFKRYDVDVSDSVH 
 
Spnp19  
MRCYTWVFTVSVFLTSAVLAIASPRWPGGNSQQRPRWELGDADFSSPITDTSFVKRLLGRIHEDLR
QKSNQAADLRDATSRGFETVDLKQLSDNGAGLQVHGVRQTRGKCMGRFGPYMLNCKRSGPTTI 
 
Spnp20 
MTSQLVTLVLAVFVCSAAVVYSQSPSSPPSASPPTVLATEPITTPRPAVATTPPPVDNGTPAPSAN
GTDAPTPVVTDAPMTSAKDGDDDGMKGDGDGQKGHDDDEEGGGGLRRGDIALAILATILVVAVICT
FIGLCYWKYKGNSYVTVTADTTYRQ 
Figure 2
Peptide              Sequence                                         Ref. 
 
Human CT             ---CG-NLSTCMLGTYTQDFNKFHTFP--QTAIGVG--APa-----   1 
Human CGRP           --ACD--TATCVTHRLAGLLSRSGGVV--KNNF-VPT-NVGSKAFa   2 
Ciona CT             ---CD-GVSTCWLHELGN--SVHATAG--GKQN-VGF-GPa-----   3 
SpCTLP               SKGCG-SFSGCMQMEVAK--NRVAALLRNSNAHLFGLNGPa-----   4 
Drosophila DH31      --TVDFGLARGYSGTQEA--KHRMGLA--AANF-AG--GPa-----   5 
Homarus DH31         --GLDLGLGRGFSGSQAA--KHLMGLA--AANF-AG--GPa-----   6 
Figure 3
Peptide                                    Sequence           Ref.   
 
SpPPLN1d                 GFNSGAMEPLGSGFI    1 
SpPPLN2h            -FG-GANEPMRSGFF    1 
Aplysia PP1-precursor peptide         PLDSVYGTHGMSGFA    2 
Aplysia PP2-precursor peptide    PVDSI-GSS----FI    2 
Aplysia PP3-precursor peptide         RLDSIAGSSGFSNFG    2 
Platynereis FDSIG-precursor peptide        SFDSIGHSSNFAGLD    3 
Caenorhabditis NLP14 peptide    ALDGLDGAGF--GFD    4 
Caenorhabditis NLP15 peptide    AFDSLAGSGFDNGFN    4 
Procambrus orcokinin-precursor peptide     NFDEIDRSGF--GFN    5 
Nasonia orcokinin-precursor peptide        NFDEIDRSGF-SGFN    6  
Figure 4
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